市场调查报告书
商品编码
1396554
生物资讯服务市场 - 类型(定序服务、数据分析)、应用(基因组学、蛋白质组学、药物基因组学)、最终用途(学术机构和研究中心、医院和诊所)、全球预测,2023 - 2032 年Bioinformatics Services Market - Type (Sequencing Services, Data Analysis), Application (Genomics, Proteomics, Pharmacogenomics), End-use, (Academic Institutes & Research Centers, Hospitals & Clinics), Global Forecast, 2023 - 2032 |
由于越来越多地采用生物资讯学工具来分析生物资料,预计从 2023 年到 2032 年,生物资讯服务市场的复合CAGR将达到 15.9%。随着对精准医疗和个人化治疗策略的需求不断增加,製药和生物技术公司越来越依赖生物资讯服务来解释复杂的基因组和蛋白质组资料。
2023 年 12 月,领先的胃肠道健康公司 Cyted 获得了 Innovate UK 的 100 万英镑资助,用于牵头开展嗜酸性粒细胞性食道炎 (EoE) 诊断和治疗反应预测的精准医疗计画。
此外,生命科学领域研发活动的增加,加上政府推动基因组学研究的倡议,正在促进市场成长。
生物资讯服务市场根据类型、应用、最终用途和区域进行分类。
资料分析领域预计将在 2023 年至 2032 年期间创下强劲的CAGR,因为它涵盖了广泛的计算技术,可以从生物资料中提取有意义的见解。这正在影响重大创新,人工智慧和机器学习演算法的整合提高了资料解释的效率和准确性。对于旨在从大规模生物数据集中获得可行见解的研究人员和临床医生来说,这种演变至关重要。
到 2032 年,蛋白质组学应用将为市场带来巨额收入,因为生物资讯服务有助于揭示蛋白质结构和功能的复杂性。用于蛋白质鑑定、表征和定量的各种解决方案的可用性使研究人员能够更深入地了解疾病机制、药物标靶和生物标记发现。由于蛋白质体学领域在推进药物发现和开发过程中发挥关键作用,预计将出现强劲成长。
在该地区强大的生命科学研发基础设施的推动下,欧洲生物资讯学服务产业预计到 2032 年将显着成长。领先的生物技术和製药公司的存在,加上支持性的政府政策和资助计划,使欧洲成为生物资讯服务提供者的中心。该地区学术机构、研究组织和产业参与者之间的合作激增,促进了生物资讯学应用的创新,从而塑造了产业前景。
Bioinformatics services market is predicted to observe 15.9% CAGR from 2023 to 2032 due to the growing adoption of bioinformatics tools for the analysis of biological data. With the escalating need for precision medicine and personalized treatment strategies, pharmaceutical and biotechnology companies are increasingly relying on bioinformatics services to interpret complex genomic and proteomic data.
In December 2023, Cyted, a leading gastrointestinal health firm, obtained a £1 million grant from Innovate UK to spearhead a precision medicine project for Eosinophilic Esophagitis (EoE) diagnosis and treatment response prediction.
Moreover, the rise in R&D activities in the life sciences sector, coupled with government initiatives promoting genomics research, is fostering market growth.
The bioinformatics services market is classified based on type, application, end-use, and region.
The data analysis segment is expected to record strong CAGR from 2023 to 2032 as it encompasses a wide array of computational techniques to extract meaningful insights from biological data. This is influencing significant innovation, with the integration of artificial intelligence and machine learning algorithms enhancing the efficiency & accuracy of data interpretation. This evolution is pivotal for researchers and clinicians aiming to derive actionable insights from large-scale biological datasets.
The proteomics application will generate massive revenues for the market by 2032 as bioinformatics services help in unraveling the complexities of protein structures and functions. The availability of various solutions for protein identification, characterization, and quantification, is enabling researchers to gain deeper insights into disease mechanisms, drug targets, and biomarker discovery. The proteomics segment is anticipated to witness robust growth owing to its pivotal role in advancing drug discovery and development processes.
Europe bioinformatics services industry is anticipated to grow significantly through 2032 driven by the region's robust infrastructure for life sciences R&D. The presence of leading biotechnology and pharmaceutical companies, coupled with supportive government policies and funding initiatives, positions Europe as a hub for bioinformatics service providers. The region is witnessing a surge in collaborations between academic institutions, research organizations, and industry players, fostering innovation in bioinformatics applications, thereby shaping the industry outlook.